Trademark: CTX110
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for CTX110
We do not have any records of a proof of use for CTX110 at this moment.
Possible trademark infringements of CTX110
Basic Information about CTX110
- Serial Number
- 88296694
- Filing Date
- 11 Feb 2019
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of CTX110 on the blockchain with WikiTrademarks.io.
- First use of CTX110 anywhere
- CTX110 was first used on 22 Jul 2019 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
- First use of CTX110 anywhere
- CTX110 was first used on 22 Jul 2019 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns CTX110?
1. CRISPR Therapeutics AG ZUG V8
2. CRISPR Therapeutics AG Basel
Correspondent
- Tiffany D. Gehrke
- Marshall Gerstein & Borun LLP
- 233 S. Wacker Drive
- Suite 6300
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io